Biodesix Inc

General ticker "BDSX" information:

  • Sector: Health Care
  • Industry: Health Care Providers & Services
  • Capitalization: $199.6M

Biodesix Inc does not follow the US Stock Market performance with the rate: -8.0%.

Estimated limits based on current volatility of 4.3%: low 1.42$, high 1.54$

Factors to consider:

  • Price in estimated range
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.05$, 2.72$]
  • 2024-12-30 to 2025-12-30 estimated range: [0.90$, 2.42$]

Financial Metrics affecting the BDSX estimates:

  • Negative: Non-GAAP EPS, $ of -0.63 <= 0.10
  • Negative: Operating profit margin, % of -45.72 <= 1.03
  • Negative: Operating cash flow per share per price, % of -15.05 <= 2.35
  • Positive: Inventory ratio change, % of 1.01 <= 1.08
  • Positive: -0.96 < Investing cash flow per share, $ of -0.28
  • Negative: negative Net income

Similar symbols

Short-term BDSX quotes

Long-term BDSX plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $54.51MM $38.21MM $49.09MM
Operating Expenses $95.45MM $88.80MM $90.43MM
Operating Income $-40.94MM $-50.59MM $-41.34MM
Non-Operating Income $-2.20MM $-14.86MM $-10.80MM
Interest Expense $4.51MM $8.07MM $9.54MM
R&D Expense $12.79MM $13.10MM $9.99MM
Income(Loss) $-43.14MM $-65.45MM $-52.15MM
Profit(Loss) $-43.14MM $-65.45MM $-52.15MM
Stockholders Equity $19.73MM $20.61MM $4.58MM
Inventory $2.90MM $1.40MM $1.40MM
Assets $76.10MM $92.91MM $99.10MM
Operating Cash Flow $-28.22MM $-44.97MM $-22.87MM
Capital expenditure $2.55MM $3.53MM $23.06MM
Investing Cash Flow $-2.55MM $-3.53MM $-23.06MM
Financing Cash Flow $1.26MM $58.88MM $29.13MM
Earnings Per Share* $-1.63 $-1.91 $-0.64

* EPS are Split Adjusted, recent splits may be reflected with a delay.